Solid Phase Assay for Detecting Biomarkers for Cardiodiabetes
The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.
1 . A composition comprising a solid support comprising:
(a) a capture binding ligand selective for adiponectin,
(b) a capture binding ligand selective for high sensitivity C-reactive protein (hsCRP) wherein the capture binding ligand can detect a hsCRP concentration of less than 10 mg/L, and
(c) a capture binding ligand selective for intact proinsulin.
2 . The composition of claim 1 wherein one of the capture binding ligands comprises an antibody.
3 . The composition of claim 1 wherein the composition further comprises:
(a) a soluble capture ligand selective for adiponectin,
(b) a soluble capture ligand selective for hsCRP, and
(c) a soluble capture ligand selective for intact proinsulin.
4 . The composition of claim 3 wherein each of the soluble capture ligands comprises a detectable marker.
5 . The composition of claim 4 wherein a detectable marker is a fluorophore.
6 . The composition of claim 4 wherein a detectable marker is a conjugated enzyme.
7 . The composition of claim 6 wherein the conjugated enzyme is horseradish peroxidase.
8 . The composition of claim 1 further comprising a detector.
9 .- 22 . (canceled)